Mohamed El-Shazly

Prof. Mohamed El-Shazly

1. Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, Ain-Shams University, Organization of African Unity Street, Abassia, Cairo 115, Egypt
+1

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
RSRakshandha Saini
Rakshandha Saini
NSNitin Sharma
Nitin Sharma
OOOluwole Solomon Oladeji
Oluwole Solomon Oladeji
ASAnuradha Sourirajan
Anuradha Sourirajan
KDKamal Dev
Kamal Dev
VKVikas Kumar
Vikas Kumar

1 November 2018 in Industrial Crops and Products
Verified
Journal Article
Closed access
NFNouran M. Fahmy
Nouran M. Fahmy
Eman Al-SayedEman Al-Sayed
Eman Al-Sayed
Mohamed El-ShazlyMohamed El-Shazly
Mohamed El-Shazly
ASAbdel Nasser Singab
Abdel Nasser Singab

3 April 2015 in Marine Drugs
Verified
Journal Article
Open access
PDF file
AEahmed elissawy
ahmed elissawy
Mohamed El-ShazlyMohamed El-Shazly
Mohamed El-Shazly
Sherif ElsayedSherif Elsayed
Sherif Elsayed
Abdel Nasser SingabAbdel Nasser Singab
Abdel Nasser Singab
Peter ProkschPeter Proksch
Peter Proksch
Marine-derived fungi continue to be a prolific source of secondary metabolites showing diverse bioactivities. Terpenoids from marine-derived fungi exhibit wide structural diversity including numerous compounds with pronounced biological activities. In this review, we survey the last five years’ reports on terpenoidal metabolites from marine-derived fungi with particular attention on those showing marked biological activities.

8 October 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Abdelhakim BOUYAHYAAbdelhakim BOUYAHYA
Abdelhakim BOUYAHYA
NONasreddine El Omari
Nasreddine El Omari
MBMohamed Bakha
Mohamed Bakha
TATarik Aanniz
Tarik Aanniz
NMNaoual El Menyiy
Naoual El Menyiy
Mohammad MubarakMohammad Mubarak
Mohammad Mubarak
Trichostatin A (TSA), a natural derivative of dienohydroxamic acid derived from a fungal metabolite, exhibits various biological activities. It exerts antidiabetic activity and reverses high glucose levels caused by the downregulation of brain-derived neurotrophic factor (BDNF) expression in Schwann cells, anti-inflammatory activity by suppressing the expression of various cytokines, and significant antioxidant activity by suppressing oxidative stress through multiple mechanisms. Most importantly, TSA exhibits potent inhibitory activity against different types of cancer through different pathways. The anticancer activity of TSA appeared in many in vitro and in vivo investigations that involved various cell lines and animal models. Indeed, TSA exhibits anticancer properties alone or in combination with other drugs used in chemotherapy. It induces sensitivity of some human cancers toward chemotherapeutical drugs. TSA also exhibits its action on epigenetic modulators involved in cell transformation, and therefore it is considered an epidrug candidate for cancer therapy. Accordingly, this work presents a comprehensive review of the most recent developments in utilizing this natural compound for the prevention, management, and treatment of various diseases, including cancer, along with the multiple mechanisms of action. In addition, this review summarizes the most recent and relevant literature that deals with the use of TSA as a therapeutic agent against various diseases, emphasizing its anticancer potential and the anticancer molecular mechanisms. Moreover, TSA has not been involved in toxicological effects on normal cells. Furthermore, this work highlights the potential utilization of TSA as a complementary or alternative medicine for preventing and treating cancer, alone or in combination with other anticancer drugs.

31 May 2021 in Plants
Verified
Journal Article
Open access
PDF file
IAIriny Ayoub
Iriny Ayoub
Michal KorinekMichal Korinek
Michal Korinek
Mohamed El-ShazlyMohamed El-Shazly
Mohamed El-Shazly
BWBernhard Wetterauer
Bernhard Wetterauer
Hesham El-BeshbishyHesham El-Beshbishy
Hesham El-Beshbishy
Fadia YoussefFadia Youssef
Fadia Youssef
This study aims to comprehensively explore the phytoconstituents as well as investigate the different biological activities of Chasmanthe aethiopica (Iridaceae) for the first time. Metabolic profiling of the leaf methanol extract of C. aethiopica (CAL) was carried out using HPLC-PDA-ESI-MS/MS. Twenty-nine compounds were annotated belonging to various phytochemical classes including organic acids, cinnamic acid derivatives, flavonoids, isoflavonoids, and fatty acids. Myricetin-3-O-rhamnoside was the major compound identified. GLC/MS analysis of the n-hexane fraction (CAL-A) resulted in the identification of 45 compounds with palmitic acid (16.08%) and methyl hexadecanoic acid ester (11.91%) representing the major constituents. CAL-A exhibited a potent anti-allergic activity as evidenced by its potent inhibition of β-hexosaminidase release triggered by A23187 and IgE by 72.7% and 48.7%, respectively. Results were comparable to that of dexamethasone (10 nM) in the A23187 degranulation assay showing 80.7% inhibition for β-hexosaminidase release. Both the n-hexane (CAL-A) and dichloromethane (CAL-B) fractions exhibited potent anti-inflammatory activity manifested by the significant inhibition of superoxide anion generation and prohibition of elastase release. CAL showed anti-hyperglycemic activity in vivo using streptozotocin-induced diabetic rat model by reducing fasting blood glucose levels (FBG) by 53.44% as compared with STZ-treated rats along with a substantial increase in serum insulin by 22.22%. Molecular modeling studies indicated that dicaffeoylquinic acid showed the highest fitting with free binding energies (∆G) of −47.24 and −60.50 Kcal/mol for human α-amylase and α-glucosidase, respectively confirming its anti-hyperglycemic activity. Thus, C. aethiopica leaf extract could serve as an effective antioxidant natural remedy combating inflammation, allergy, and hyperglycemia.

1 March 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
NONasreddine El Omari
Nasreddine El Omari
FGFatima Ezzahrae Guaouguaou
Fatima Ezzahrae Guaouguaou
NMNaoual El Menyiy
Naoual El Menyiy
TBTaoufiq Benali
Taoufiq Benali
TATarik Aanniz
Tarik Aanniz
Abdelhakim BOUYAHYAAbdelhakim BOUYAHYA
Abdelhakim BOUYAHYA